Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

One minoxidil-sensitive potassium channel exists in human hair follicles.

Hair loss in men treated best with early medication or transplant, new treatments researched.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Dermatoscopy is a useful tool for diagnosing hair disorders and can help choose samples for more detailed analysis.

Some breast cancer chemotherapy can cause permanent hair loss.

The document concludes that good cosmetic outcomes in hair transplantation depend on the surgeon's artistic skill and careful planning.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Modern hair transplants use small grafts for a natural look and drugs to prevent further loss, with high patient satisfaction.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Cosmetics enhance beauty, fix defects, and intimidate enemies, with varying cultural standards and alternative methods.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

Loose anagen hair syndrome, often affecting young girls, can be diagnosed with a hair-pull test and usually gets better on its own, but severe cases may need treatment.

Intense pulsed light (IPL) is an efficient and safe method for hair removal, reducing hair by about 80%.